News

News

No. Title Written by Date Read
16 Research on STCube’s Small Molecule Immunotherapeutic Agent for Pancreatic Cancer Published in Prestigious Scientific Journal Admin 20.12.09 106
15 STCube, Inc. Obtains U.S. Patent for Proprietary Anti-PD-1 Antibody Admin 20.10.30 108
14 Enter into CDMO Agreement with Samsung Biologics /Eyes of CEO/Hankyung TV Admin 20.08.13 558
13 STCube signs additional development and manufacturing agreement with Samsung Biologics Admin 20.07.12 204
12 STCube Presents Data on Its Proprietary PD-1 Antibody at AACR Admin 20.06.23 277
11 STCube Applies for a U.S. Patent on the COVID-19 Anti-viral Treatment Using 'STT-003' Admin 20.03.30 193
10 STCube Initiates a CRO Contract for Development of COVID-19 Treatment Using ‘STT-003’ Admin 20.03.23 191
9 STCube Publishes Research Paper on Its Antibody to Immune-checkpoint Inhibitor PD-1 in Cancer Research, an International Academic Journal Admin 20.03.12 199
8 STCube and Samsung Biologics Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug Admin 20.03.03 214
7 STCube Obtains EU Patent for Screening Method for Cancer Immunotherapy Candidates Using Radiation Admin 19.11.28 3,448